Statement of Ownership (sc 13g)
February 17 2015 - 2:58PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
COHERUS
BIOSCIENCES INC.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
19249H103
(CUSIP Number)
November 12, 2014
(Date of Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule
13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
* |
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
Page 1
13G
|
|
|
|
|
CUSIP No. 19249H103 |
|
|
|
Page 2 of 5 Pages |
|
|
|
|
|
|
|
1. |
|
Name of
reporting persons: Daiichi Sankyo Company, Limited |
2. |
|
Check the appropriate box if a member
of a group (a) ¨ (b) ¨ |
3. |
|
SEC use only
|
4. |
|
Citizenship or place of
organization: Japan |
Number of
shares beneficially
owned by each
reporting person
with |
|
5. |
|
Sole voting power:
2,867,426 |
|
6. |
|
Shared voting power:
0 |
|
7. |
|
Sole dispositive power:
2,867,426 |
|
8. |
|
Shared dispositive power:
0 |
9. |
|
Aggregate amount beneficially owned by each reporting person:
2,867,426 |
10. |
|
Check box if the aggregate amount in
Row (9) excludes certain shares (see instructions) ¨ |
11. |
|
Percent of class represented by amount
in Row (9): 8.62% |
12. |
|
Type of reporting person (see
instructions): CO |
Page 2
Item 1. |
(a). Name of Issuer |
Coherus BioSciences, Inc. (the Company)
(b). Address of Issuers Principal Executive Offices:
201 Redwood Shores Parkway
Suite
200
Redwood City, CA 94065
Item 2(a). |
Name of Person Filing |
Daiichi Sankyo Company, Limited
Item 2(b). |
Address of Principal Business Office |
The principal business office is:
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo 103-8426, Japan
Daiichi Sankyo Company, Limited is a Japanese corporation.
Item 2(d). |
Title of Class of Securities: |
Common Stock, par value $0.0001 per share (the
Common Stock)
19249H103
Item 3. |
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
(a) Amount beneficially owned:
As of the date hereof, Daiichi Sankyo Company, Limited beneficially owns 2,867,426 shares of Common Stock of the Company.
(b) Percent of class:
Daiichi Sankyo Company, Limited is the beneficial owner of 8.62% of Common Stock of the Company. The percentage for Daiichi Sankyo Company,
Limited is calculated using a denominator of 33,257,978 shares of Common Stock outstanding as of November 30, 2014.
Page 3
(c) Number of Shares as to which the Reporting Person has:
(i) Sole power to vote or to direct the vote:
2,867,426 shares.
(ii) Shared
power to vote or to direct the vote:
0.
(iii) Sole power to dispose or to direct the disposition of:
2,867,426 shares.
(iv) Shared
power to dispose or to direct the disposition of:
0.
Item 5. |
Ownership of Five Percent or Less of a Class |
If this statement is being
filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person. |
Not
applicable.
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
Not applicable.
Item 8. |
Identification and Classification of Members of the Group. |
Not
applicable.
Item 9. |
Notice of Dissolution of Group. |
Not Applicable.
Not Applicable.
Page 4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 17, 2015
|
|
|
|
|
DAIICHI SANKYO COMPANY, LIMITED |
|
|
|
|
|
By: |
|
/s/ Kazunori Hirokawa |
|
|
Name: |
|
Kazunori Hirokawa |
|
|
Title: |
|
Senior Executive Officer |
Page 5
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Apr 2023 to Apr 2024